Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06HMI
|
||||
Former ID |
DCL000924
|
||||
Drug Name |
PF-00547659
|
||||
Drug Type |
Antibody
|
||||
Indication | Ulcerative colitis; Inflammatory bowel disease [ICD9: 555, 556, 556.9; ICD10:K50, K50-K52, K51] | Phase 2 | [536371] | ||
Company |
Pfizer
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H23N3O5
|
||||
Canonical SMILES |
CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(<br />C)C
|
||||
InChI |
1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1
|
||||
InChIKey |
RXIUEIPPLAFSDF-CYBMUJFWSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Mucosal addressin cell adhesion molecule 1 | Target Info | [536371] | ||
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | a4b7 Integrin signaling | ||||
Beta5 beta6 beta7 and beta8 integrin cell surface interactions | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.